TNFSF11 and osteosarcoma: Additionally, in cases of skeletal metastases of unknown primary (SMUP) coexisting with osteosarcoma, both diseases may exhibit RANK/RANKL pathway dysregulation and increased bone turnover markers such as CTX and alkaline phosphatase.